Widecells Group PLC (LON:WDC) Chief Executive Officer João Andrade caught up with DirectorsTalk for an exclusive interview to discuss the recent Board changes, their new scientific advisory board, WG Partners..
Widecells Group Plc (LON:WDC) CEO João Andrade talks to DirectorsTalk about the strengthening of its management and advisory team through the appointment of three new board members, the creation of..
Widecells Group PLC (LON:WDC) Chief Executive Officer João Andrade caught up with DirectorsTalk for an exclusive interview to discuss CellPlan’s launch in Spain Q1: Yet more exciting news for..
Widecells Group PLC (LON:WDC) Chief Executive Officer João Andrade caught up with DirectorsTalk for an exclusive interview to discuss their new exclusive agreement with White Apex to expand into MENA..
WideCells Group PLC (LON:WDC), the healthcare services company focused on providing stem cell services and ground-breaking insurance for stem cell treatment, has today announced that its 100% owned subsidiary CellPlan..
WideCells Group PLC (LON:WDC) CEO João Andrade talks to DirectorsTalk about an exclusive Heads of Terms agreement with multi-sector advisory business White Apex General Trading, to sell and promote the..
WideCells Group PLC, the healthcare services company focused on providing stem cell services and ground-breaking insurance for stem cell treatment, has announced its interim results for the 6 months ended..
Widecells Group PLC (LON:WDC) Chief Executive Officer João Andrade and Vice President of WideAcademy Alan Greenberg caught up with DirectorsTalk for an exclusive interview to discuss WideAcademy, what it is..
Widecells Group Plc (LON:WDC) CEO João Andrade & Vice President of WideAcademy Alan Greenberg talks to DirectorsTalk about the development of a bespoke stem cell focused educational platform to deliver..
WideCells Group PLC (LON:WDC) Chief Executive Officer João Andrade caught up with DirectorsTalk for an exclusive interview to discuss the successful placing of £750,000, what it will be used for,..
Widecells Group Plc (LON:WDC) CEO João Andrade talks to DirectorsTalk about the successful placing of £750,000. João explains how the money will be used, how the future looks bright for..
WideCells Group PLC (LON:WDC), the healthcare services company focused on providing stem cell services and ground-breaking insurance for stem cell treatment, has today announced that it has raised gross proceeds..
WideCells Group PLC (LON:WDC), the healthcare services company focused on regenerative medicine including the provision of stem cell services and ground-breaking insurance for stem cell treatment, has today announced that..
WideCells Group PLC (LON:WDC) Chief Executive Officer João Andrade and Chief Scientific Officer Dr Peter Hollands caught up with DirectorsTalk for an exclusive interview to discuss the launch of their..
WideCells Group PLC (LON:WDC) has announced its one-year anniversary to the London Stock Exchange. The Group was established in order to transform the stem cell industry by creating the first..
Widecells Group Plc (LON:WDC) Chief Executive Officer, João Andrade and Chief Scientific Officer Dr Peter Hollands join DirectorsTalk to discuss two product launches. João explains how the CellPlan e-commerce platform..
WideCells Group PLC (LON:WDC), the healthcare services company focused on regenerative medicine, including the provision of stem cell services and ground-breaking insurance for stem cell treatment, has become a licenced..
WideCells Group PLC (LON:WDC), the healthcare services company focused on providing stem cell services and ground-breaking insurance for stem cell treatment, was today delighted to announce that the e-commerce platform..
WideCells Group PLC (LON:WDC), the healthcare services company focused on providing stem cell services and ground-breaking insurance for stem cell treatment, was today delighted to announce that it has finalised..
WideCells Group PLC (LON:WDC) Chief Executive Officer João Andrade and Chief Financial Officer David Bridgland caught up with DirectorsTalk for an exclusive interview to discuss the agreement with Hemocord, the..
